Bio Innovation Conference | Agenda At-a-glance
page-template,page-template-full_width,page-template-full_width-php,page,page-id-10,ajax_fade,page_not_loaded,,qode-child-theme-ver-1.0.0,qode-theme-ver-17.2,qode-theme-bridge,qode_header_in_grid,wpb-js-composer js-comp-ver-5.6,vc_responsive

Agenda At-a-glance

october 7, 2019 •  bethesda north marriott hotel & conference center

    Monday, October 7, 2019

    7:30 am Registration Open | Exhibit Hall Open | Breakfast and Networking
    7:30 am-8:30 am BIO Partnering Meetings
    8:30 am-8:40 am Welcome and Opening Remarks
    8:45 am-9:45 am
    (concurrent panel sessions)


    Track 1

    Changing the Landscape for Cell and Gene Therapy
    Maryland’s Center of Excellence

    Margot Connor, Chief Executive Officer, RoosterBio

    Emily English, Ph.D., Chief Executive Officer, Gemstone Therapeutics
    Kimberly Noonan, Ph.D., Founder, Executive Vice President and Chief Scientific Officer, WindMIL Therapeutics
    William Rust, Ph.D., Chief Executive Officer and Co-Founder, Seraxis

    Track 2

    The Friends and Family Plan
    Experts discuss different levels of early stage fundraising

    Jeff Galvin, Chief Executive Officer and Founder, American Gene Technologies

    Judy Costello, Managing Director, Economic Development, BioHealth Innovation
    Henry Ahn, SBIR/STTR Program Director, National Science Foundation – Invited
    Joseph Naft, Director, Maryland Industrial Partnerships (MIPS) Program
    Paul Silber, Founding Principal, Blu Venture Investors

    10:00 am – 11:00 am
    Sponsored by Maxcyte

    Keynote Address
    Hopes for a Cure – Gene Therapy for Sickle Cell Anemia

    Keynote Speaker:
    John F. Tisdale, M.D., Senior Investigator, National Heart, Lung and Blood Institute

    11:15 am-12:15 pm
    (concurrent panel sessions)


    Track 1

    Life Saving Therapies, Heart Stopping Prices
    Navigating Reimbursement

    Brian Abraham, Director,Market Access, Life Sciences, BDO

    Track 2

    Employment Opportunities Fulfilled
    The demand for life sciences job skills is growing rapidly in this region. Our roundtables will discuss opportunities and challenges while determining actions which can be taken to ensure workforce readiness and availability for the near-, mid- and long-term.

    12:15 pm-1:30 pm
    Sponsored by Towson University

    Networking Lunch in the Exhibit Hall
    BIO Partnering Meetings

    1:30 pm-2:30 pm
    (concurrent panel sessions)


    Track 1


    David Feigal, M.D., MPH, Partner, NDA Partners

    Track 2

    Strategic Market Planning for Capital and Commercialization
    Experts discuss key considerations and timing for market assessments to drive strategic partnering options and optimized commercial launch success

    Steven Walker, MBA, MHA, Chief Business Officer and Commercial Strategist, Biologics Consulting

    Luis Gutierrez, Past President, Commercialization Services, Covance
    Ram Palanki, Pharm.D., Senior Vice President of Commercial Strategy and Operations, REGENXBIO
    Tyrell Rivers, Ph.D., Executive Director of Corporate Development, AstraZeneca

    2:45 pm-3:45 pm
    (concurrent panel sessions)


    Track 1

    New Frontiers of Biomanufacturing

    Track 2

    Past Seed Stage to the Last Mile
    Experts discuss later stage fundraising opportunities

    Linda Segal, Principal, The McCormick Group

    Subhendu Basu, Ph.D., Senior Director and Department Head, Scientific Affairs, CSO & Executive Offices, Emergent BioSolutions
    Diana Bernstein, Ph.D., Senior Associate, Merck Ventures
    Pete Buzy, Chief Executive Officer, Paragon Biosciences
    Jacob Vogelstein, General Partner, Camden Partners

    4:00 pm-5:00 pm

    Keynote Address

    5:00 pm-6:00 pm

    Cocktail Reception

    STAY INFORMED. Join our mailing list to receive our email newsletter.